Keywords: Chelsea Therapeutics, Northera, Hypotension, Blood pressure, Phase III

Chelsea Thera shares jump as Ph III trial of Northera meets primary endpoint

Article | 21 September 2010

USA-based biotech firm Chelsea Therapeutics International (Nasdaq: CHTP) says its shares leap nearly 40% to $6.96 in early trading yesterday, after the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Chelsea Therapeutics

Go to company listing

Related Drugs

Northera

Go to drug listing